ArticleFrontiers in surgery2022

Neoadjuvant Immuno-Chemotherapy: A New Perspective for Stage III NSCLC?

Yuanshan Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.